2-AMINO-3-(5-IODO-1H-INDOL-3-YL)PROPANOIC ACID, 95.0%, 1g

1,2-Dibromo-4-methyl-5-nitrobenzene, 95.0%, 1g

4-Aminopyridazin-3(2H)-one, 95.0%, 1g

Zernike phase contrast set PLPH 10/20/40/100 bright field and dark field position

N,N,N',N'-Tetramethylbenzidine>98.0%(GC)(T)1g

2-Chloro-6-methoxypyridine>98.0%(GC)25g

rel-((1R,5S)-3-Azabicyclo[3.1.0]hexan-6-yl)methanol, 95+%, 1g

Sodium 3-(benzothiazol-2-ylthio)-1-propanesulfonate, 99.0%, 1kg

tert-Butyl (R)-3-((R)-(3-chlorophenyl)(hydroxy)methyl)piperidine-1-carboxylate, 95%, 250mg

1,3-Bis(benzyloxy)-2-propanol, 95.0%, 5g

Methyl 4-(Hydroxymethyl)benzoate>98.0%(T)5g

4-Methylhex-3-enoic acid, 95.0%, 1g

2-(4-Methyl-piperazin-1-yl)-ethylamine, 99.00%, 100g